{"organizations": [], "uuid": "ccbf9073eb1fe13d1492593d53b582b7aaef6c68", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-biolife-solutions-says-co-and-savs/brief-biolife-solutions-says-co-and-savsu-technologies-amended-their-arrangement-with-respect-to-jv-idUSFWN1PL19R", "country": "US", "domain_rank": 408, "title": "BRIEF-Biolife Solutions Says Co And Savsu Technologies Amended Their Arrangement With Respect To JV", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-27T00:36:00.000+02:00", "replies_count": 0, "uuid": "ccbf9073eb1fe13d1492593d53b582b7aaef6c68"}, "author": "", "url": "https://www.reuters.com/article/brief-biolife-solutions-says-co-and-savs/brief-biolife-solutions-says-co-and-savsu-technologies-amended-their-arrangement-with-respect-to-jv-idUSFWN1PL19R", "ord_in_thread": 0, "title": "BRIEF-Biolife Solutions Says Co And Savsu Technologies Amended Their Arrangement With Respect To JV", "locations": [], "entities": {"persons": [{"name": "savsu techno", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "brief-biolife solutions says co", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "biolife solutions inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 26 (Reuters) - Biolife Solutions Inc:\n* BIOLIFE SOLUTIONS SAYS ON JAN 22 CO AND SAVSU TECHNOLOGIES AMENDED THEIR ARRANGEMENT WITH RESPECT TO THEIR JV, BIOLOGISTEX- SEC FILING\n* BIOLIFE SOLUTIONS- AS RESULT OF CONTRIBUTION AGREEMENT AMENDMENT ON JAN 22, WILL NOW MAINTAIN 35% OWNERSHIP STAKE IN JV, SUBJECT TO ORDINARY DILUTION\n* BIOLIFE - AS RESULT OF OPERATING AGREEMENT AMENDMENT ON JAN 22, CO WILL GET 35% OF PROFITS,LOSSES OF JV, SUBJECT TO ORDINARY DILUTION, MOVING FORWARD Source text - bit.ly/2nfsMys Further company coverage:\n ", "external_links": [], "published": "2018-01-27T00:36:00.000+02:00", "crawled": "2018-01-27T00:54:41.011+02:00", "highlightTitle": ""}